Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 15.5B | 16.1B | 16.6B | 17.3B |
Cost of revenue | 5.8B | 6.4B | 6.5B | 6.7B |
Gross profit | 9.7B | 9.7B | 10.0B | 10.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 4.5B | 2.8B | 2.9B | 2.9B |
Other operating expenses | 15.4M | 2.9B | 2.3B | 2.1B |
Operating income | 5.2B | 4.0B | 4.9B | 5.5B |
Non operating interest income | ||||
Income | 251.4M | 285.0M | 367.4M | 384.2M |
Expense | 540.6M | 602.1M | 593.7M | 583.9M |
Other income expense | 762.7M | 234.7M | 36.3M | -1.1B |
Pretax income | 5.7B | 3.9B | 4.7B | 4.2B |
Tax provision | 1.0B | 828.4M | 740.4M | 875.9M |
Net income | 4.7B | 3.1B | 4.0B | 3.4B |
Basic EPS | 0.2 | 0.1 | 0.2 | 0.1 |
Diluted EPS | 0.2 | 0.1 | 0.2 | 0.1 |
Basic average shares | 16.2B | 16.2B | 16.3B | 16.2B |
Diluted average shares | 16.3B | 16.3B | 16.3B | 16.3B |
EBITDA | 6.3B | 5.2B | 6.4B | 7.0B |
Net income from continuing op. | 4.7B | 3.1B | 4.0B | 3.4B |
Minority interests | -7.0M | -25.1M | -2.8M | 14.0M |
Preferred stock dividends | — | — | — | — |